GLOBEIMMUNE INC Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GBIM and buy or sell other stocks, ETFs, and their options commission-free!About GBIM
GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform.
CEOTimothy C. Rodell, Jr., MD
CEOTimothy C. Rodell, Jr., MD
Employees3
Employees3
HeadquartersLouisville, Colorado
HeadquartersLouisville, Colorado
Founded1995
Founded1995
Employees3
Employees3
GBIM Key Statistics
Market cap575.20
Market cap575.20
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume3.99K
Average volume3.99K
High today$0.0001
High today$0.0001
Low today$0.0001
Low today$0.0001
Open price$0.0001
Open price$0.0001
Volume35.90K
Volume35.90K
52 Week high$0.0401
52 Week high$0.0401
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 575.2, GLOBEIMMUNE INC Common Stock(GBIM) trades at $0.00.
During the trading session on 2026-09-08, GLOBEIMMUNE INC Common Stock(GBIM) shares reached a daily high of $0.00 and a low of $0.00. At a current price of $0.00, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading volume for GLOBEIMMUNE INC Common Stock(GBIM) stock has reached 35.9K, versus its average volume of 3.99K.
The stock's 52-week range extends from a low of $0.00 to a high of $0.04.
The stock's 52-week range extends from a low of $0.00 to a high of $0.04.